Commentary · 21 Feb 2026
Conference abstractPublished 26 Sep 2016
The effect of human mesenchymal stem cells on glioblastoma cultures in vitro
University of Medicine and Pharmacy of Craiova, Romania Bagdasar-Arseni Emergency Hospital, Romania
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Glioblastoma, a tumor with high vascularity, contains a mixture of cells including malignant cancer cells, cancer stem cells, brain endothelial cells, microglia cells astrocytes and different stromal cell types. The interaction between the tumor and the microenvironment was suggested to be an important factor in the response to therapy. Mesenchymal stem cells (MSCs), an important part of the glioblastoma microenvironment, were explored by many researchers as a new approach for treating cancer diseases. However, the results are controversial; some studies have indicated that MSCs may play a role in cancer therapy by killing malignant cells, while others found that MSCs promote cancer and metastasis. Here, we analyzed the effect of human MSC-conditioned medium on glioblastoma (GB) cells survival in vitro. In this study we evaluated the in vitro effect of human MSC-conditioned medium on glioblastoma (GB) cells viability. For this purpose, we used bone morrow derived MSC (hBM-MSC) purchased from Life Technologies and MSC derived from umbilical cord tissue (HUC-1 and HUC-2) established from human umbilical cord tissue, obtained after term natural births at the Emergency County Hospital of Craiova, Romania. GB cell cultures were established from fresh samples tissue obtained from GB patients undergoing surgery at the Bagdasar- Arseni Hospital, Bucharest. All biological samples were obtained from informed consent subjects. We found that HUC-1 and HUC-2 conditioned medium inhibited proliferation of the GB cell lines as compared to control cells. The treatment with HUC- 1- or HUC-2- conditioned medium for 96 h induced about 20% cell death in all GB cell lines used in this study. Regarding hBM-MSC, we found that hBM-MSC-conditioned medium treatment enhanced GB cell growth 24 h after the treatment, while prolonged treatment for 96 h showed minor inhibition of GB cell growth.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Daniela Elise Tache”
- BylineArticles whose byline prints “Roxana Folcuti”
- BylineArticles whose byline prints “Stefana Oana Purcaru”
- BylineArticles whose byline prints “Oana Alexandru”
- BylineArticles whose byline prints “Ligia Gabriela Tataranu”
- BylineArticles whose byline prints “Anica Dricu”
